Clinical Trial Update: A Phase 1b Study of WU-NK-101 in Combination With Cetuximab [Phase 1]

View source ↗

Summary

A Phase 1b trial evaluates WU-NK-101 in combination with cetuximab for metastatic colorectal cancer and head and neck squamous cell carcinoma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• WU-NK-101 (WU-NK-101)

Snippet

Sponsor: Wugen, Inc. | Conditions: Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck | Phase 1 | Status: ACTIVE_NOT_RECRUITING